Although to a lesser extent, the CD4 T-cell proportion also was higher in DLBCL than in control samples (tumor/spleen fold change: 1.3e+01, p ≤1.0e-6) (Figure S1A and Table S4). This evidence concerns the gene CD4 and neoplasm.